FDA Inspection 857661 — Bristol-Myers Squibb Company
The FDA completed an inspection of Bristol-Myers Squibb Company on Nov 22, 2013 in New Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 22, 2013
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- New Brunswick, NJ (United States)